NYSE$DOV
Dover Corp · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Dover's Q1 2023 results were released, showcasing revenue growth and solid execution amidst inflationary and foreign currency translation headwinds.
Dover reported a 1% increase in revenue to $2.1 billion for Q1 2023, with organic revenue up by 3%. GAAP diluted EPS increased by 4% to $1.63, while adjusted diluted EPS rose by 2% to $1.94. The company maintains its full-year adjusted EPS guidance.
- Revenue grew across the majority of Dover's portfolio due to the recovery in global supply chains and solid demand.
- New order intake was healthy and encouraging for the rest of the year.
- Margin performance was as expected, with four out of five segments improving year-over-year margins.
- The company is on track to deliver its full-year cash flow target by liquidating inventory.
Headline financials
Revenue & EPS history
Dover · Revenue · Quarterly
$2.08B
Revenue by segment
Dover · $2.08B total across 5 segments · Q1 2023
- Engineered Products$498M+2.0%23.9%
- Climate & Sustainability Tech$455M+14.1%21.9%
- Clean Energy & Fueling$431M-6.0%20.7%
- Pumps & Process Solutions$414M-4.9%19.9%
- Imaging & Identification$283M+4.0%13.6%
Forward guidance
Dover expects full year 2023 GAAP EPS in the range of $7.81 to $8.01 (adjusted EPS of $8.85 to $9.05), based on full year revenue growth of 3% to 5%.
Tailwinds
- Dover is on track to deliver its full year cash flow target as it liquidates inventory in concert with a normalization of its backlog.
- Demand conditions in attractive industrial markets remain solid.
- Bookings are healthy.
- Elevated backlog levels, especially in some longer-cycle businesses, provide good visibility to the full year forecast.
- Prior investments in automation, productivity projects, and cost actions are delivering the benefits necessary to offset inflationary input costs.
Headwinds
- Inflationary headwinds.
- Foreign currency translation headwinds.
- Pumps and Process Solutions segment margins were lower due to the mix effect of lower biopharma volumes.
- Mixed macroeconomic backdrop.
- Diligently monitoring customers’ plans.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
+0.9%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.7%
Avg return
30 days after
58%
41 / 71 earnings
Positive
+12.1%
Q4 2018
Best reaction
-8.1%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +6.3% | +3.7% | -2.9% | |
| Q4 2025 | -3.4% | +2.7% | +9.5% | |
| Q3 2025 | +8.2% | +7.2% | +9.5% | |
| Q2 2025 | -1.9% | -1.7% | -5.4% | |
| Q1 2025 | +2.0% | +2.3% | +6.9% | |
| Q4 2024 | +4.1% | +2.8% | +0.7% | |
| Q3 2024 | -2.5% | +0.1% | +6.8% | |
| Q2 2024 | +5.0% | +4.6% | +4.7% | |
| Q1 2024 | +5.1% | +4.6% | +7.4% | |
| Q4 2023 | +6.0% | +7.4% | +11.7% | |
| Q3 2023 | -2.8% | -4.1% | +3.5% | |
| Q2 2023 | -3.5% | -4.2% | -7.1% | |
| Q1 2023 | -0.6% | +0.7% | -5.8% | |
| Q4 2022 | +9.3% | +11.4% | +5.6% | |
| Q3 2022 | +2.9% | +4.9% | +14.9% | |
| Q2 2022 | +2.3% | +1.2% | +9.7% | |
| Q1 2022 | -8.1% | -10.6% | -15.9% | |
| Q4 2021 | -1.7% | -0.1% | -6.4% | |
| Q3 2021 | +1.2% | +1.5% | +5.9% | |
| Q2 2021 | +8.0% | +8.1% | +13.5% | |
| Q1 2021 | +6.0% | +5.5% | +5.4% | |
| Q4 2020 | -2.1% | +0.3% | +3.6% | |
| Q3 2020 | +0.9% | +3.1% | +10.6% | |
| Q2 2020 | +2.2% | +2.7% | +6.2% | |
| Q1 2020 | +0.4% | +5.8% | +5.7% | |
| Q4 2019 | -2.2% | +0.1% | -11.7% | |
| Q3 2019 | +6.7% | +8.7% | +14.2% | |
| Q4 2018 | +12.1% | +10.6% | +14.2% | |
| Q3 2018 | +0.2% | +0.5% | +6.6% | |
| Q2 2018 | +8.2% | +6.8% | +13.2% | |
| Q1 2018 | -1.5% | -4.6% | +4.1% | |
| Q4 2017 | +2.4% | -0.4% | -5.6% | |
| Q3 2017 | +1.5% | +2.5% | +0.7% | |
| Q2 2017 | -2.7% | -1.1% | -1.6% | |
| Q1 2017 | +0.1% | +2.5% | +4.9% | |
| Q4 2016 | -2.1% | -4.6% | -1.7% | |
| Q3 2016 | +1.0% | +2.1% | +3.9% | |
| Q2 2016 | -2.4% | -1.0% | +1.8% | |
| Q1 2016 | -0.7% | — | — | |
| Q4 2015 | +4.2% | — | — | |
| Q3 2015 | +7.2% | — | — | |
| Q2 2015 | -2.6% | — | — | |
| Q1 2015 | -1.5% | — | — | |
| Q4 2014 | -3.3% | — | — | |
| Q3 2014 | +3.4% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | +3.2% | — | — | |
| Q4 2013 | -3.5% | — | — | |
| Q3 2013 | +0.7% | — | — | |
| Q2 2013 | +6.1% | — | — | |
| Q1 2013 | -5.0% | — | — | |
| Q4 2012 | -2.0% | — | — | |
| Q3 2012 | +1.3% | — | — | |
| Q2 2012 | +4.6% | — | — | |
| Q1 2012 | -4.1% | — | — | |
| Q4 2010 | +1.0% | — | — | |
| Q4 2011 | +1.0% | — | — | |
| Q3 2011 | +0.4% | — | — | |
| Q2 2011 | +0.4% | — | — | |
| Q1 2011 | +3.4% | — | — | |
| Q3 2010 | -2.5% | — | — | |
| Q2 2010 | +5.4% | — | — | |
| Q1 2009 | +6.7% | — | — | |
| Q1 2010 | -0.3% | — | — | |
| Q4 2009 | +1.2% | — | — | |
| Q4 2007 | +1.2% | — | — | |
| Q3 2009 | -3.8% | — | — | |
| Q3 2008 | -3.8% | — | — | |
| Q4 2008 | -5.5% | — | — | |
| Q2 2009 | -5.5% | — | — | |
| Q2 2008 | -5.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro